PRAME T-cell therapy cleared six metastatic tumor sites in a 17-year-old with terminal kidney cancer, according to a case ...

A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic ...

New antibodies recognize mutant KRAS fragments displayed on tumor cells, unlocking a way to target pancreatic, colorectal, ...

When a new type of immunotherapy called CAR T-cell therapy was approved by the US Food and Drug Administration in 2017, it gave patients who had exhausted other treatment options hope where there was ...

An innovative type of CAR T cell therapy, called KIR-CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine patients with advanced ...

The CancerVax platform is designed to harness the body’s existing immunity to detect, mark, and kill cancer cells with ...

For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving. Doctors remove a patient's immune cells, called T cells, engineer them in ...

Researchers at the USC Viterbi School of Engineering and Keck School of Medicine of USC have engineered a remarkable genetic tool that addresses one of the most persistent obstacles in cancer ...

The treatment eliminated a boy's tumors with a single infusion.